Skip to content

How it works

Adding tissue to a weak cornea

It makes biological sense to add tissue to a thin, weak cornea rather than remove more tissue from the weakest part of it.

CAIRS was first described by Dr Soosan Jacob and colleagues in 2018, and was first performed in Australia in 2021.

  • Adds tissue

    Donor stroma is added to a thin, weak cornea. None of the patient’s own cornea is removed.

  • Removable

    Segments can be removed or exchanged later if the cornea changes or the correction needs adjusting.

  • Planned from tomography

    Segment size and position are planned from corneal tomography, and several published nomograms guide segment width and thickness.

  • Works alongside cross-linking

    Cross-linking can be added when there is evidence of progression, at the same time as CAIRS or separately.

Keratoconus care

Where CAIRS sits in keratoconus care

Treatment for keratoconus is stepwise, CAIRS is one of several options, and every patient’s plan is individual.

  1. 1

    Stop eye rubbing

    The strongest avoidable driver of progression, and the first step for every patient.

  2. 2

    Reshape the cornea

    CAIRS improves the shape of the cornea by adding donor tissue inside a laser-cut channel.

  3. 3

    Cross-link if progressing

    Corneal cross-linking where there is evidence of progression. Stable corneas do not generally need it.

  4. 4

    Refine vision

    Glasses, soft contact lenses, implantable contact lenses (ICLs) or sequential topography-guided laser for remaining refractive error.

  5. 5

    Transplant if needed

    PK or DALK for the minority whose keratoconus continues to progress despite the steps above.

Balanced information

Risks and limitations

As with any corneal surgery, CAIRS carries risks. Reported risks include infection, thinning or melting of the cornea over a segment, and over- or under-correction. Some patients need further surgery, including removal or exchange of a segment, and many still need glasses or contact lenses for their best vision.

The published evidence is growing, but most studies are case series with limited long-term follow-up.

CAIRS relies on corneal tissue donated through eye banks. The society acknowledges the generosity of donors and their families.

Planning

Planning CAIRS

Segment size and position are planned from corneal tomography. Several published nomograms guide segment width and thickness, and each plan is individual to the eye being treated.

FAQ

Questions about CAIRS

Is CAIRS a corneal transplant?

CAIRS uses donor corneal tissue, but it does not replace any of the patient’s cornea. Arcs of donor stroma are placed inside a channel in the patient’s own cornea to reshape it. In penetrating keratoplasty (PK) or deep anterior lamellar keratoplasty (DALK), part or all of the central cornea is removed and replaced with donor tissue.

Can CAIRS segments be removed?

Yes. Segments can be removed or exchanged later, for example if the cornea changes over time or the correction needs adjusting.

Does CAIRS replace corneal cross-linking?

No. CAIRS reshapes the cornea, while cross-linking is used to stop keratoconus progressing. Cross-linking is added when there is evidence of progression, either at the same time as CAIRS or as a separate procedure.

Is everyone with keratoconus suitable for CAIRS?

No. Suitability depends on corneal thickness, the shape and severity of the cone, scarring and other findings on corneal tomography. A transplant remains the right operation for some patients. Your optometrist or ophthalmologist can advise whether CAIRS may suit your eyes.

Clinicians new to CAIRS can start with the society’s literature list.